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Stem cell therapy to improve cardiac function after myocardial infarction is hampered by
poor cell retention, while it may also increase the risk of arrhythmias by providing an arrhyth-
mogenic substrate. We previously showed that porcine adipose tissue-derived-stromal cells
(pASC) induce conduction slowing through paracrine actions, whereas rat ASC (rASC) and
human ASC (hASC) induce conduction slowing by direct coupling. We postulate that bioma-
terial microspheres mitigate the conduction slowing influence of pASC by interacting with
paracrine signaling.
Aim
To investigate the modulation of ASC-loaded recombinant human collagen-based micro-
spheres, on the electrophysiological behavior of neonatal rat ventricular myocytes (NRVM).
Method
Unipolar extracellular electrograms, derived from microelectrode arrays (8x8 electrodes)
containing NRVM, co-cultured with ASC or ASC loaded microspheres, were used to deter-
mine conduction velocity (CV) and conduction heterogeneity. Conditioned medium (Cme) of
(co)cultures was used to assess paracrine mechanisms.
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Results
Microspheres did not affect CV in control (NRVM) monolayers. In co-cultures of NRVM and
rASC, hASC or pASC, CV was lower than in controls (14.4±1.0, 13.0±0.6 and 9.0± 1.0 vs.
19.5±0.5 cm/s respectively, p<0.001). Microspheres loaded with either rASC or hASC still
induced conduction slowing compared to controls (13.5±0.4 and 12.6±0.5 cm/s respectively,
p<0.001). However, pASC loaded microspheres increased CV of NRVM compared to pASC
and NRMV co-cultures (16.3±1.3 cm/s, p< 0.001) and did not differ from controls (p = NS).
Cme of pASC reduced CV in control monolayers of NRVM (10.3±1.1 cm/s, p<0.001), similar
to Cme derived from pASC-loaded microspheres (11.1±1.7 cm/s, p = 1.0). The presence of
microspheres in monolayers of NRVM abolished the CV slowing influence of Cme pASC
(15.9±1.0 cm/s, p = NS vs. control).
Conclusion
The application of recombinant human collagen-based microspheres mitigates indirect
paracrine conduction slowing through interference with a secondary autocrine myocardial
factor.
Introduction
Stem cell-based therapy is an experimental clinical therapeutic option to improve cardiac func-
tion and remodeling in post-myocardial infarction patients[1–4]. Poor retention and survival
of administered cells[5, 6] are known to limit the therapeutic efficiency of cell-based therapy.
Secondly, potential pro-arrhythmic effects of administrated cells or e.g. their secreted mole-
cules are of concern but are inadequately investigated[7–10]
Compared to adult cardiomyocytes that have a resting membrane potential of about -90
mV, mesenchymal stem cells are relatively depolarized, with a resting membrane potential of
approximately -35 mV[11, 12]. Therefore, direct—electrotonic- coupling between stem cells
and cardiac myocytes will exert electrophysiological effects that alter the electrophysiology that
can result in conduction slowing [7, 8, 10] and reentrant arrhythmias [13, 14].
The rationale to employ mesenchymal stem cells in cardiac therapy is their potent paracrine
capacity[15]. There is consensus that the hemodynamic benefit of stem cells on cardiac func-
tion seen in several pre-clinical post-(acute) myocardial infarction studies is mediated by para-
crine signaling. However, little is known about the paracrine interaction [16–18] between stem
cells and cardiomyocytes and the possible effects on the electrophysiology[7, 10].
We have recently shown that adipose tissue-derived stromal cells (ASC) cause heteroge-
neous conduction slowing in cultured neonatal rat ventricular myocytes (NRVM) monolayers.
Interestingly, we observed species-dependent differences. Rat ASC (rASC) and human ASC
(hASC) altered conduction velocity (CV) via direct—electrotonic- interaction, while porcine
ASC (pASC) slowed conduction of NRVM in a paracrine fashion[10]. Conditioned medium
of pASC alone induced conduction slowing, suggesting secreted factors from pASC induced
the observed conduction slowing [10].
The delivery of stem cells loaded onto or captured inside biomaterials is widely explored to
improve cell retention, engraftment as well as function (recently reviewed in[19]). Presently,
biomaterials such as hydrogels[20], scaffolds[21], patches[22] and microspheres[23, 24] are
used to investigate improvements in retention and engraftment. Because specific microspheres,
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based on collagen, have been shown to absorb factors (e.g. bone morphogenetic protein-2 and
basic fibroblast growth factor) and release this over time[25, 26], we hypothesized that the myo-
cardial conduction slowing effects caused by paracrine interaction between myocytes and ASC
derived from porcine are mitigated in the presence of these microspheres. The mitigated effects
are expected to be absent in co-cultures of NRVM and ASC derived from rat and man, as these
cells induced conduction slowing through direct–electrotonic-coupling (Fig 1).
Similar to mesenchymal stem cells, cardiomyocytes have complex paracrine and autocrine
signaling networks[27]. It is therefore plausible that these autocrine networks are affected by
pASC-secreted factors, resulting in changes that can influence e.g. conduction velocity. For
that reason, by selective exposure of cardiomyocytes to the paracrine factors in the conditioned
media, of pASC, in the presence or absence of our microspheres we aimed to identify the
source of the paracrine factor responsible for conduction slowing, being either the ASC (pri-
mary, direct paracrine effect) and/or the myocytes (secondary indirect autocrine effect).
We used recombinant human collagen-based microspheres (MS), similar to those used in
our earlier studies that showed an excellent time-dependent degradation and remodeling in
Fig 1. Schematic overview of the hypothesis that recombinant human collagen-based microspheres mitigate the conduction slowing induced
by pASC. From previous work we know that rASC and hASC induce conduction slowing through direct-electrotonic-coupling (1) and that pASC paracrine
factors alone can induce conduction slowing in NRVM monolayers (2). We hypothesize that the microspheres will buffer the pASC paracrine factors, and
mitigate the conduction slowing (3). The mitigating effect can also be achieved when the pASC are loaded onto the microspheres (4). When rASC or hASC
are loaded onto the microspheres conduction slowing will still occur as these cells induce conduction slowing through direct-electrotonic-coupling(5).
Abbreviations: hASC: human adipose tissue-derived stromal cells, NRVM; neonatal rat ventricular myocytes, pASC: porcine adipose tissue-derived stromal
cells, and rASC: rat adipose tissue-derived stromal cells.
https://doi.org/10.1371/journal.pone.0183481.g001
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vivo[23]. Furthermore these MS can be loaded with ASC, without changing their biological
properties such as proliferation rate and secreted factors[24]. The current study demonstrates
that specific biomaterial guided stem cell application mitigates pro-arrhythmic paracrine con-
duction slowing through interference with a yet unidentified, secondary autocrine myocardial
factor.
Materials and methods
All animal experiments were approved by the local Animal Experiments Committee (Aca-
demic Medical Center, University of Amsterdam (permit number DCA-192AA1) and carried
out in accordance with national and institutional guidelines. Human ASC were obtained from
liposuction material (Bergman Clinics, The Netherlands), and was considered as anonymized
waste material. However, every anonymized donor gave his/her informed consent for scien-
tific research. Porcine subcutaneous abdominal fat (male, 3–4 months) was provided by the
Department of Experimental Surgery of the Academic Medical Center. Inguinal rat fat (male,
Wistar, 7–8 months) was provided by the Department of Pathology and Medical Biology, Uni-
versity Medical Center Groningen. In both cases the animals were used in different experi-
ments and this tissue was considered waste material.
Preparation of neonatal rat ventricular myocyte monolayers
Neonatal rat ventricular myocytes (NRVM) were isolated and cultured as described previously
[10]. Briefly, hearts were obtained from one to two days old Wistar rats. Atria were removed
and the ventricles, once cut into pieces, were dissociated with trypsin (1 mg/mL; Becton Dick-
inson BV, Breda, The Netherlands) and collagenase type 2 (1 mg/mL, Worthington Vollen-
hove, The Netherlands, 230 units/mg). Fibroblast contamination was minimized by a two
hour pre-plating step. Ventricular myocytes were then seeded at 1.4 x 105/cm2 density onto
fibronectin (125 μg/ml BD Biosciences, Breda, The Netherlands) coated microelectrode arrays
(MEAs; Multi Channel Systems MCS GmbH, Reutlingen, Germany). This array has 60 inte-
grated extracellular electrodes aligned in an 8 by 8 matrix at interelectrode distances of 0.7 mm
(S1 Fig). NRVM were cultured in culture medium (M199 medium; Gibco) supplemented with
10% heat inactivated fetal bovine serum (FBS; Gibco), 1% HEPES (Gibco #5630-0-80), 5000
U/L penicillin-G (Sigma,#P7794), 2 mg/L vitamin B12 (Sigma, #V2876), 3.5 g/L glucose, 1%
non-essential amino acids (Gibco, #11140–050), and 1% L-glutamine (Gibco,#25030–081).
Light microscopy was used to determine if a confluent (and spontaneous beating) monolayer
had formed in each of the cultures. A total of 24 cell isolations were performed to execute the
experiments.
Isolation and culture of adipose tissue-derived stromal cells
Porcine, rat and human adipose tissue derived stromal cells (ASC) were isolated and cultured
as previously described[10, 28, 29]. Briefly, collected tissue was minced and washed in phos-
phate buffered saline before the dissociation steps with collagenase A (0.1%, Roche Diagnos-
tics, Mannheim, Germany). The obtained stromal vascular fraction was incubated with
erythrocyte lysis buffer before the cells were seeded at a density of 4 x 104 cells/cm2. Culture
medium consisted of DMEM (Lonza Biowhittaker, Verviers, Belgium), supplemented with
10% FBS (Thermo Scientific, Hemel Hempstead, UK), 100 U/mL penicillin, 100 mg/mL strep-
tomycin (Gibco, Invitrogen, Carlsbad, CA) and 2 mM L-glutamine (Lonza Biowhittaker,Ver-
viers, Belgium). ASC were propagated at a 1:2 ratio and used from passage 3 onwards.
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Experimental conditions
Mitomycin-C (Sigma M4287-2MG) treated ASC were labeled with CDFA-SE (Invitrogen
Vybrand1 CFDA SE Cell Tracer Kit) before they were collected with accutase. ASC were
added to four days old monolayers of NRVM in cell ratio of NRVM:ASC 1:1. On the same day
monolayers of NRVM serving as controls received fresh culture medium containing 2% FBS.
Two days later electrical mapping was performed. The co-cultures were named NRVM + ASC
indicating that NRVM and ASC were cultured together.
Preparation of ASC-loaded recombinant human collagen-based
microspheres
Recombinant human collagen-based microspheres (MS) were provided by Fujifilm[23, 24].
Microspheres were prepared from an RGD enriched human collagen I derived recombinant
peptide (commercially available under the tradename Cellnest™(Fuji Film). Details of micro-
sphere production, size and structure can be found in the S1 Appendix.
Of the MS, 10 mg was incubated in 10 mL ASC culture medium and stored at 4˚C until MS
were loaded with ASC. Mitomycin-C-treated and SDFA-SE (Invitrogen Vybrand1 CFDA-SE
Cell Tracer Kit)-labeled ASC were loaded onto MS (at 2.5 x 105 ASC per mg) in low-adherent
T6 wells with ASC culture medium and left overnight at 37˚C in 5% CO2. The following day
the cell/microsphere suspension was collected and centrifuged at 160 g for 5 minutes. Superna-
tant was removed and the pellet was re-suspended in an equal amount of NRVM culture medi-
um containing 2% FBS, the cell/microsphere suspension was then added to the appropriate
monolayers; the NRVM:ASC ratio used was 1:1.
Monolayers of NRVM with bare MS (NRVM/ MS) were made on the same day as co-cul-
tures and two days later electrical measurements were performed. The different co-cultures
were named NRVM + ASC/MS indicating that NRVM and ASC loaded microspheres were
cultured together.
Conditioned medium
Different types of conditioned media were used. Conditioned medium (Cme) was removed,
after 48 hours, from confluent cultures of pASC or cultures consisting of pASC loaded MS, fil-
tered (0,22 μm) and stored at -20˚C until use. This medium was referred to as Cme [pASC]
and Cme [pASC/MS] respectively. Cme was also removed, after 48 hours, from monolayers of
NRVM containing pASC loaded MS, this medium was filtered (0.22μm) and stored at -20˚C
until use, and was referred to as Cme [NRVM + pASC/MS].
Monolayers of NRVM/ MS were incubated with Cme [pASC] and received this medium 8
hours after microspheres were added to give the microspheres an opportunity to sediment on
the NRVM monolayer.
Electrical mapping and microelectrode measurements
Electrical mapping was performed as previously described[10]. Briefly, cultures grown on
multi-electrode arrays were stimulated, on day 6 of culture, using a bipolar extracellular stimu-
lus electrode (twice diastolic stimulation threshold, 1 or 2 ms rectangular current pulses).
At each local electrogram activation time (AT) was determined as the interval from the
stimulation artefact to the minimum derivative of the local QRS. The minimum derivative
(dV/dt) threshold was set at -0.1 mV/ms. From these AT activation maps were constructed.
Conduction velocity (CV) was determined along lines perpendicular to isochronal lines by
dividing the distance by the difference in local activation time. Lines had a length of at least 4
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electrode distances[10]. Based on the method described by Lammers et al.[13] we quantified
the heterogeneity in conduction. Resting membrane potential was taken as the highest nega-
tive membrane potential recorded and Vmax (upstroke velocity) was taken as dV/dt max. All
signal analysis were performed using a custom-made data analysis program written in Matlab
2006b (The MathWorks Inc, Natick, MA)[30]. For each experiment (cell isolation) two mono-
layers of NRVM only served as control. Monolayers that were not beating spontaneously or
un-excitable when stimulated were discarded.
Following activation mapping, action potentials were recorded in control cultures, co-cul-
tures of NRVM and pASC loaded microspheres and monolayers of NRVM cultured in Cme
pASC. Microelectrodes were pulled from borosilicate glass capillaries (Harvard apparatus
GC100F-10) and filled with 3 M KCl. An AgCl covered silver wire was used as a reference elec-
trode. Typical tip resistance was 15 and 25 MO.
Immunostainings
Cells plated in 12-wells plate used for immunofluorescence were cultured under the same con-
ditions and timing as cells on MEAs. Cells were permeabilized after fixation in 4% PFA and
blocked before staining with primary antibodies (rabbit anti Connexin 43 (Invitrogen
574366A; 1:200) and mouse anti N-Cadherin (Sigma C2542, 1:100)) and secondary antibodies
(Alexa Fluor-488 goat anti-mouse IgG (Life Technology, A21235; 1:250), Alexa Fluor-647 goat
anti- rabbit IgG (Life Technology, A11008/A21222; 1:250)). Nuclei were stained with DAPI
(Sigma, D9542, 1:40000). Examination was performed by Leica SPE confocal laser scanning
and Leica Application Suite Advanced Fluorescence software. Immunofluorescence images
were analyzed using Image J version 1.50i (National Institutes of Health, NIH, USA) as
described previously[10].
Statistical analysis
Data that were continuous and normally distributed are presented as mean ± SEM, and com-
pared using an independent t-test. In case of more than two groups an one-way ANOVA was
performed with the Bonferroni correction as post-hoc analysis. The conduction heterogeneity
data showed a skewed distribution and hence are presented as median with the interquartile
range (IQR) and tested with the Mann Whitney U test. In case of more than two groups a
Kruskal-Wallis analysis was performed with post-hoc analysis using the Dunn’s test. A p-value
of<0.05 was considered significant.
Results
Cell characterization
Scanning electron microscopy of ASC-loaded MS, revealed that ASC had adhered and spread
over the surface (Fig 2) of the recombinant human collagen-based MS. Adhered ASC also
bridged multiple microspheres. No signs of apoptosis (e.g. blebbing) were observed. The
micrographs obtained with the scanning electron microscope also show the rough surface and
porous nature of the microspheres. Confluent monolayers of NRVM cultured with and with-
out ASC and ASC-loaded MS were visualized with light microscopy at day six (Fig 3).
Influence of recombinant human collagen-based microspheres on
conduction parameters in monolayers of NRVM
Monolayers of NRVM showed normal, homogeneous propagation (Fig 4A). Monolayers of
NRVM cultured with bare microspheres also demonstrated normal, homogeneous
Recombinant collagen-based microspheres mitigate conduction slowing
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propagation. The CV in monolayers of NRVM in contact with bare microspheres (NRVM/
MS) did not differ from control monolayers without microspheres (17.9±0.9 vs. 19.3±0.5 cm/s,
Fig 2. Scanning electron microscope micrographs of the recombinant human collagen-based microspheres loaded with porcine ASC. Original
magnification is indicated underneath the image. Abbreviation: ASC: adipose tissue-derived stromal cells.
https://doi.org/10.1371/journal.pone.0183481.g002
Fig 3. Light microscope image of the two main cell types used and the different cultures. A: Monolayers of NRVM cultured on multi-electrode
arrays, B: Porcine ASC in culture, C: Monolayers of NRVM cultured together with microspheres, D: Co-cultures of NRVM and porcine ASC on a multi-
electrode array and E: Co-cultures of NRVM and porcine ASC loaded on microspheres. Original magnification 10x. Black dots represent electrode
terminals in the multi-electrode arrays. Abbreviations; ASC: adipose tissue-derived stromal cells, MS: microspheres and NRVM: neonatal rat ventricular
myocytes.
https://doi.org/10.1371/journal.pone.0183481.g003
Recombinant collagen-based microspheres mitigate conduction slowing
PLOS ONE | https://doi.org/10.1371/journal.pone.0183481 August 24, 2017 7 / 20
NRVM/MS and NRVM respectively, Fig 4B). Conduction heterogeneity in monolayers of
NRVM cultured with MS also did not differ from controls (5.2 (1.4) vs. 5.0 (2.3) ms, NRVM/
MS and NRVM respectively, Fig 4C).
Influence of recombinant human collagen-based microspheres on
conduction slowing mediated by a paracrine mechanism
Co-cultures of NRVM and pASC showed heterogeneous conduction slowing compared to the
control monolayers studied on the same day. Conduction velocity was 9.0±1.0 cm/s in co-cul-
tures (NRVM + pASC) compared to 19.5±0.5 cm/s in control monolayers (NRVM, p<0.001,
Fig 5B). Conduction heterogeneity was increased in the co-cultures with pASC relative to con-
trols (11.6 (9.4) vs. 5.4 (2.3) ms, NRVM + pASC and NRVM respectively, p<0.001, Fig 5C).
In monolayers co-cultured with pASC loaded MS (NRVM+pASC/MS) conduction was
similar to control (NRVM) monolayers. Overall, conduction velocity in NRVM+pASC/MS
was 16.3±1.3 cm/s vs. 19.5±0.5 cm/s, in control cultures (NRVM, p = 0.08, Fig 5B). Conduc-
tion heterogeneity in NRVM+pASC/MS was 5.1 (2.5) vs. 5.4 (2.3) ms in control cultures
(NRVM, p = 0.92, Fig 5C). Both conduction velocity and heterogeneity differed significantly
from co-cultures with bare pASC (NRVM + pASC, CV: 9.0±1.0 cm/s, p< 0.001, heterogene-
ity: 11.6 (9.4) ms, p<0.01, Fig 5B and 5C).
Conditioned medium obtained from pASC cultures induced conduction slowing and
increased conduction heterogeneity (Fig 6, 2nd bar), as demonstrated before[10]. We tested
Fig 4. Effects of recombinant human collagen-based microspheres on NRVM monolayers. A: An
activation map of a monolayer of NRVM (left) and a monolayer of NRVM cultured with microspheres (right).
Conduction velocities are determined along the white arrows perpendicular to isochronal (black) lines. The
effects of culturing bare microspheres on monolayers of NRVM on B: conduction velocity and C: conduction
heterogeneity. Number of replicates per experimental condition is indicated in the bar-graphs. Abbreviations;
MS: microspheres and NRVM: neonatal rat ventricular myocytes.
https://doi.org/10.1371/journal.pone.0183481.g004
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whether the mitigated effect of the microspheres (Fig 5) was related to primary paracrine
effects derived from the porcine stem cells (pASC). To test this, conditioned medium obtained
from cultures of pASC- loaded microspheres was applied to control NRVM monolayers. In
these monolayers conduction velocity was also lower than in controls (11.1±1.7 vs. 19.5±0.4
cm/s, p< 0.001, Fig 6A, 3rd bar) and conduction heterogeneity was higher than in controls
(10.9 (14.6) vs. 6.3 (2.0) ms, p<0.01, Fig 6B). Conduction velocity and its heterogeneity did not
differ between monolayers of NRVM cultured in conditioned medium of pASC or those cul-
tured in conditioned medium of pASC loaded microspheres (Fig 6, 2nd and 3rd bar).
The experiments so far showed that the conduction slowing effect of pASC in monolayers
of NRVM is based on a paracrine effect and that this effect (conduction slowing) is absent in
the presence of the microspheres in co-cultures of NRVM and pASC (Fig 5B, 3rd bar). How-
ever, conduction velocity is not normalized in monolayers of NRVM cultured in conditioned
medium obtained from cultures of pASC-loaded microspheres (Fig 6, 3rd bar). This suggested
that the microspheres did not buffer the paracrine mediators of the pASC as we originally
assumed. Thus, we hypothesized that conduction slowing is generated from the cardiomyo-
cytes as a secondary or indirect paracrine effect induced by the pASC paracrine factors and
Fig 5. Influence of recombinant human collagen-based microspheres on conduction slowing
mediated by a paracrine mechanism. A: Activation map of a monolayer of NRVM co-cultured with pASC
(left), and an activation map of a monolayer of NRVM cultured with pASC loaded microspheres (right).
Conduction velocity is determined along the white arrows perpendicular to isochronal (black) lines. Lower
panels: the effects on B: conduction velocity and C: conduction heterogeneity. * indicates p< 0.001 compared
to the NRVM + pASC. Number of replicates per experimental condition is indicated in the bar-graphs.
Abbreviations; MS: microspheres, NRVM: neonatal rat ventricular myocytes, and pASC: porcine adipose
tissue-derived stromal cells.
https://doi.org/10.1371/journal.pone.0183481.g005
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that the microspheres interfere with this secondary myocardial factor. It also implies that the
microspheres should be in direct contact with the NRVM in order to suppress the conduction
slowing effect of the ASC conditioned medium.
We tested this by incubating monolayers of NRVM with microspheres prior to exposing
these to conditioned medium obtained from pASC. In these cultures conduction velocity did
not differ from control NRVM monolayers (15.9±1.0 vs. 19.5±0.4, p = 0.1, Fig 6A, 4th bar).
Similarly, heterogeneity did not differ between these two conditions (7.8 (1.45) vs. 6.3 (2.0),
p> 0.1, Fig 6B). Conduction velocity under these conditions, however, differed significantly
from monolayers of NRVM cultured in conditioned medium of pASC and conditioned
medium of pASC-loaded microspheres (compare to Fig 6A, 2nd and 3rd bar). Thus, the para-
crine mediators responsible for conduction slowing are derived from NRVM secondary to
exposure to Cme pASC. We surmise that the recombinant human collagen-based micro-
spheres neutralize these NRVM-derived paracrine mediators.
We further tested this by deriving conditioned medium from co-cultures of NRVM and
pASC loaded microspheres and adding this conditioned medium to a control culture of
NRVM. We expected that the primary, porcine derived paracrine factors contained in the
Cme would maintain its effect on the NRVM monolayer, leading to a secondary autocrine
effect resulting in conduction slowing. Fig 6 (last bar) shows that under these conditions, con-
duction was slower than control and did not differ from cultures of NRVM cultured in condi-
tioned medium of pASC (Fig 6A, last and 2nd bar). Conduction heterogeneity demonstrated
the corresponding effects (Fig 6B).
Upstroke velocity of action potentials and Cx43. The degree of depolarization is a main
determinant in conduction velocity and a theoretical sigmoid relationship between RMP and
Vmax (upstroke velocity) exists[31, 32]. From the previous study we observed that ASC
Fig 6. Effects of conditioned medium. The effects on A: conduction velocity and B: conduction heterogeneity of monolayers
of NRVM cultured in various conditioned mediums. * indicates p 0.05. Number of replicates per experimental condition is
indicated in the bar-graphs. Abbreviations; Cme: conditioned medium, MS: microspheres, NRVM: neonatal rat ventricular
myocytes and pASC: porcine adipose tissue-derived stromal cells. See text for details.
https://doi.org/10.1371/journal.pone.0183481.g006
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depolarized the co-cultures[10]. Here, we recorded action potentials from monolayers of NRVM
co-cultured with pASC loaded microspheres, monolayers of NRVM cultured in conditioned
medium and control monolayers. Conditioned medium of pASC depolarized monolayers (-51.2
±1.8mV) compared to control monolayers (-65.6±1.5, p<0.01, Fig 7A) and monolayers cultured
with pASC loaded microspheres (-61.6±2.9 mV, p<0.01). The resting membrane potential did
not differ between control monolayers and monolayers cultured with pASC loaded micro-
spheres (p = ns, Fig 7A). We next looked at the relation between RMP and Vmax in these three
cultures. Fig 7B shows a sigmoid function fitted through the combined data points (black line).
Because the average data do not appear to deviate from the theoretical sigmoid function the fig-
ure show that the degree of depolarization is the main determinant of the Vmax and that the
relation was not different between the groups as was seen before[10].
We previously demonstrated that the ratio of Cx43/N-Cadherin was lower in co-cultures of
NRVM and pASC[10]. In the present study we used control cultures and co-cultures of
NRVM and pASC loaded microspheres and NRVM cultured in pASC conditioned medium to
determine the ratio of Cx43/N-Cadherin. The ratio of Cx43/N-Cadherin in the co-culture with
pASC loaded microspheres (0.97±0.03) did not differ from control monolayers (1.10±0.10,
p = ns, Fig 8). Monolayers of NRVM cultured in pASC conditioned medium demonstrated
significantly lower Cx43/N-Cadherin ratio (0.67±0.03) compared to controls (p<0.001) and
co-cultures with pASC loaded microspheres (p<0.001).
Influence of recombinant human collagen-based microspheres on
conduction slowing mediated by contact based mechanism
Rat ASC. Monolayers of NRVM co-cultured with rat ASC (rASC) showed decreased conduc-
tion velocity and increased heterogeneity compared to control monolayers (Fig 9B, [10]).
When rASC-loaded microspheres were used, conduction velocity and heterogeneity did not
differ from co-cultures containing bare rASC (13.5±0.4 vs.14.4±1.0 cm/s and 8.1 (1.9) vs. 8.8
Fig 7. The relationship between RMP and Vmax. A: The effect of conditioned medium and pASC loaded
microspheres on the RMP. B: The relationship between RMP and Vmax in the different cultures * indicates
p 0.05. Number of cells analyzed is indicated in the bar-graphs. Abbreviations; Cme: conditioned medium,
MS: microspheres, NRVM: neonatal rat ventricular myocytes, pASC: porcine adipose tissue-derived stromal
cells, and RMP: resting membrane potential.
https://doi.org/10.1371/journal.pone.0183481.g007
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(3.8) ms,Fig 9B and 9C, 3rd bar vs. 2nd bar). However, compared to control monolayers, con-
duction velocity was decreased (13.5±0.4 vs. 20.3±0.6 cm/s, p<0.001, respectively, Fig 9B, 1st
bar vs. 3rd bar) and heterogeneity had increased (8.1 (1.9) vs. 5.9 (1.9) ms, p< 0.01, Fig 7C).
Human ASC. Human ASC(hASC) in co-culture with NRVM did not differ from rASC with
respect to electrophysiological effects. Monolayers of NRVM co-cultured with hASC showed
heterogeneous conduction slowing compared to control monolayers (CV: 13.0±0.6 vs. 18.7
±0.6 cm/s respectively, p< 0.001 and heterogeneity: 11.9 (5.9) vs. 6.4 (3.5) ms, p< 0.01, Fig 9E
+ F, 2nd bar vs. 1st bar) as shown previously[10]. After application of hASC-loaded micro-
spheres heterogeneous conduction slowing was still observed and CV and heterogeneity did
not differ from co-cultures containing bare hASC. Compared to control monolayers of
NRVM, co-cultures with hASC-loaded microspheres had decreased conduction velocity (12.6
Fig 8. Immunofluorescence micrographs of cultures stained with N-cadherin and Cx43. A: A
monolayer of NRVM, a monolayer of NRVM cultured in pASC conditioned medium and a monolayer of NRVM
co-cultured with pASC loaded microspheres are stained for N-Cadherin and Cx43. B:The ratio of Cx43:
N-Cadherin in the various cultures, determined by the number of pixels. Ratios are based on 5–10 images
taken in each of three independent cultures. * indicates p< 0.05. Abbreviations; Cme: conditioned medium,
Cx43: connexin 43, MS: microspheres, NRVM: neonatal rat ventricular myocytes and pASC: porcine adipose
tissue-derived stromal cells.
https://doi.org/10.1371/journal.pone.0183481.g008
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±0.5 vs. 18.7±0.6 cm/s, p<0.001, Fig 9E, 3rd bar vs. 1st bar) and increased heterogeneity (9.7
(6.3) vs. 6.4 (3.5) ms, p<0.01, Fig 9F, 3rd vs. 1st bar).
Discussion
In this study, we investigated whether human recombinant collagen-based microspheres
loaded with ASC mitigate the conduction slowing effects of unaccompanied ASC on a conflu-
ent layer of neonatal rat ventricular cardiomyocytes. We demonstrated earlier that ASC from
three species cause heterogeneous conduction slowing. Human and rat ASC exert a direct-
electrotonic-coupling effect, those from porcine exert paracrine effects[10]. In the current
study, we show that application of bare microspheres has no effect on conduction properties of
NRVM monolayers (Fig 4). This is an important necessity of any biomaterial if it is to be used
for clinical myocardial therapy. Secondly, we demonstrated that microspheres loaded with
rASC or hASC do not influence the conduction properties of cultured cardiomyocytes differ-
ently compared to bare rASC or hASC (Fig 9). In contrast, pASC-loaded microspheres nor-
malized conduction properties of NRVM compared to co-cultures with unaccompanied pASC
(Fig 5). Finally, we demonstrated that the mere presence of MS in monolayers of NRVM, abol-
ished the conduction slowing induced indirectly by paracrine pASC factors. We speculate that
Fig 9. Influence of recombinant human collagen-based microspheres on conduction slowing mediated by a contact based mechanism. Activation
maps of A: monolayers of NRVM cultured with rASC and rASC loaded microspheres, respectively. The effect on conduction velocity (B) and conduction
heterogeneity (C) are determined along the white arrows perpendicular to isochronal (black) lines. Activation maps of D: monolayers of NRVM cultured with
hASC and hASC loaded microspheres, respectively. The effect on conduction velocity (E) and conduction heterogeneity (F) are determined along the white
arrows perpendicular to isochronal (black) lines.* indicates p< 0.001 compared to the monolayers of NRVM. Number of replicates per experimental condition
is indicated in the bar-graphs. Abbreviations; hASC: human adipose tissue-derived stromal cells, MS: microspheres, NRVM: neonatal rat ventricular
myocytes, and rASC: rat adipose tissue-derived stromal cells.
https://doi.org/10.1371/journal.pone.0183481.g009
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the MS buffer the secondary autocrine myocardial factor(s) produced by NRVM in response
to the pASC secreted factors, schematically summarized in Fig 10.
First, we reasoned that the microspheres used in our experiments acted as an absorbent/
adsorbent for the unidentified paracrine mediator(s) released specifically by pASC[10]. It
could be argued that the pASC were inactivated by the presence of the microspheres. However,
previous work demonstrated that ASC maintain their secretion profile when loaded onto the
microspheres[24]. Secondly, when we applied conditioned medium produced by pASC in the
presence of microspheres, onto a monolayer of NRVM, heterogeneous conduction slowing
was still observed (Fig 6). This indicates that pASC are not inactivated by the microspheres.
However, it also implied that the microspheres do not buffer the secreted pASC factors, as we
first speculated. We next hypothesized, that the MS buffered the secondary autocrine myocar-
dial factor(s) produced by NRVM in response to the pASC secreted factors. This is supported
by the experiments.
Next, we observed that the conduction slowing effect is mitigated when pASC loaded
microspheres are cultured together with NRVM (Fig 5). However, when we applied condi-
tioned medium from these co-cultures (Cme [NRVM + pASC/MS]) onto a monolayer of
NRVM, heterogeneous conduction slowing was observed (Fig 6). The observations can be
Fig 10. Schematic illustration of how the recombinant human collagen-based microspheres mitigate the
conduction slowing induced indirectly by porcine adipose tissue-derived stromal cells. (1) pASC secrete (a)
paracrine factor(s) that induce NRVM to produce (a) secondary autocrine factor(s) that is responsible for the observed
heterogeneous conduction slowing (2). When the microspheres are added to monolayers of NRVM, either bare or
loaded with pASC, the secondary autocrine myocardial factor is buffered by the microspheres and the conduction
slowing is mitigated (3). Abbreviations; NRVM: neonatal rat ventricular myocytes and pASC: porcine adipose tissue-
derived stromal cells.
https://doi.org/10.1371/journal.pone.0183481.g010
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explained by hypothesizing the presence of a secondary paracrine factor derived from NRVM.
In the first observation, pASC release factors that induce the NRVM to secrete a secondary
autocrine myocardial factor(s) which is buffered by the MS. In the second experiment the con-
ditioned medium applied to a new monolayer of NRVM, contains no secondary autocrine
myocardial factors, as these were buffered, but does contain pASC paracrine mediators. These
pASC derived mediators are now able to induce the NRVM to produce the secondary auto-
crine myocardial factor again, resulting in conduction slowing, as there were no microspheres
to buffer the newly produced secondary factor. This is further strengthened by the experiments
in which conditioned medium of pASC was applied to monolayers of NRVM cultured in the
presence of the human recombinant collagen-based MS. In these cultures (NRVM/MS + Cme
[pASC]), conduction was normalized (Fig 6), as in the presence of the MS the secondary auto-
crine myocardial factor was buffered.
It is plausible that the mitigating effect of conduction slowing by the recombinant human
collagen-based microspheres is caused by preventing physical contact between ASC and the
cardiomyocytes. However, we demonstrated before[10] and in the current study, that physical
contact between porcine ASC and cardiomyocytes is not required for heterogeneous conduc-
tion slowing. When bare pASC or factors secreted from pASC are cultured with NRVM het-
erogeneous conduction slowing is observed in monolayers of NRVM. Secondly, the scanning
electron microscope showed that ASC formed an interconnected layer on and between micro-
spheres indicating that the ASC were connected, most likely by cell adhesion molecules or oth-
erwise adhesive molecules. The binding of ASC to microspheres does not preclude their
juxtacrine interaction with NRVM monolayers. Earlier studies from our group, have shown
that mesenchymal-like cells in fact do interact via juxtacrine connections with neonatal cardio-
myocytes[33].
Data from the microelectrode recordings demonstrated that the relation (typically a sig-
moid relation[31, 32]) between RMP and Vmax (upstroke velocity) of the action potentials
recorded was not different between the groups. The immune-histochemical stainings (Fig 8)
demonstrated that conduction slowing is independent of the presence of (p)ASC(a structural
factor), as the ratio of Cx43/N-Cadherin was not changed in the co-culture with pASC loaded
microspheres but was lower in the Cme pASC condition. This strongly suggests that functional
changes underlie the observed conduction slowing.
Finally, we do not see a mitigating effect on conduction slowing when rASC or hASC are
loaded onto the microspheres. This suggests that the previously observed electrotonic influ-
ence of rASC and hASC on NRVM is maintained when loaded onto the microspheres.
Taken together the current investigation demonstrates that the factors released by pASC
initiate NRVM to secrete secondary–autocrine- factors that cause conduction slowing. Con-
duction slowing is an important contributor to reentry based arrhythmias[34]. In the presence
of our recombinant human collagen-based microspheres, irrespective of loading with pASC,
these myocardial autocrine factors are inactivated, absorbed, adsorbed, or buffered.
Whether the beneficial hemodynamic effects of stem cell therapy outweigh the pro-arrhyth-
mic effects remains a topic of debate. It may be argued that the application of a biomaterial
leads to a diminution of not only the adverse electrophysiological effects but also of the benefi-
cial effects of stem cells. Our study does not allow conclusions on this aspect. However, a
recent paper by de Jong et al., has demonstrated that intracoronary administration of encapsu-
lated mesenchymal stem cells into a myocardial infarct swine model did not diminish the
hemodynamic effect of the mesenchymal stem cells[35]. This is important to know because
human ASC are now recognized to have a prominent paracrine role in modulating post myo-
cardial infarction inflammation and having augmented hemodynamic effects via paracrine
mechanisms[15, 36].
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Cardiomyocytes communicate in multiple ways. Direct communications can occur through
juxtacrine connections but also via gap junctions. Communication also happens via signaling
interactions of the extracellular matrix. Thirdly, paracrine communication, although involving
a complex network of soluble factors, plays an important role[27, 37]. Pedrotty et al., investi-
gate paracrine effects of fibroblast on conduction properties of cardiomyocytes. Unidentified
factors released by cardiac fibroblasts were able to induce conduction slowing by altering ion
channel expression and inducing hypertrophy[38]. Similar results were obtained by Askar
et al., who demonstrated that paracrine factors released by mesenchymal stem cells induced
conduction slowing and increased re-entry inducibility. Askar et al., further demonstrated that
these effects are mediated by directly secreted factors, because mesenchymal stem cell derived
exosomes (micro vesicle-associated factors) did not have an effect[7]. In another study on the
effects of fibroblast on cardiomyocytes, cardiomyocyte hypertrophy was observed. In that
study it was demonstrated that transforming growth factor beta (TGFβ) had an bidirectional
regulatory signaling role between the fibroblasts and cardiomyocytes[39]. Factors such as
TGFβ are involved or expressed in response to hypertrophy and loss of adhesions. Modifica-
tions due to paracrine signaling in e.g. cell size, (gap) junctions and ion channel expression
can all result in alterations in conduction.
Our study does not allow identification of the factors released by the pASC nor the NRVM,
that indirectly and directly result in conduction slowing, because this would require an exten-
sive proteomics-based approach. However, our data strongly points into the direction of a
myocyte derived soluble factor for the generation of conduction slowing. We also emphasize
the potential role of biomaterial microspheres as a tool to mitigate adverse electrophysiological
effects of ASC.
Conclusions
Our previous results indicated that ASC cause heterogeneous conduction slowing when cul-
tured on a monolayer of NRVM[10]. Paracrine modulation and intercellular coupling between
the ASC and NRVM contribute to the formation of a potentially pro-arrhythmic substrate.
Here, we show that application of recombinant human collagen-based microspheres loaded
with pASC normalizes the electrophysiological properties of a monolayer of NRVM compared
to monolayers of NRVM co-cultured with unaccompanied pASC, through interference/
adsorption of an unidentified, secondary, autocrine, myocardial factor. The mitigating effect
of these recombinant human collagen-based microspheres is absent in co-cultures with rat
and human ASC, that display predominant direct coupling effects.
Perspectives
The fact that our recombinant human collagen-based microspheres do not influence conduc-
tion velocity in monolayers of NRVM is a positive result which does not obstruct cardiac clini-
cal applications of stem cells. We have further shown that there is inherent risk in the use of
mesenchymal stem cells for cardiac cell-based therapies and that the mechanisms are species
dependent. These clues obtained from in vitro work are important for translation towards the
clinic and can be used to improve therapy such that the pro-arrhythmic risks are reduced.
Although, pASC influence conduction via indirect paracrine effects, hASC do this via direct–
electrotonic-interactions. Our data imply that biomaterial guided stem cell therapy may miti-
gate the potentially electrophysiological pro-arrhythmic side effects of ASC and that it has a
possible role in the treatment of cardiovascular disease. In order to e.g. prevent the direct-elec-
trotonic effects of hASC, these cells could be embedded in biomaterial, allowing continuously
release of paracrine factors, while not negatively affecting the cardiac electrophysiology.
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Therefore, further development of biomaterials as carriers for stem cells for cardiac therapy
is warranted. Not only does the ‘behavior’ of stem cells, such as ASC, depend on the nature
and 3D-formulation of a biomaterial, but it is plausible to reason that different biomaterials,
either cell-loaded or bare, will influence cardiac function at the electrophysiological level, too.
In the current study, we showed that the mere presence of recombinant human collagen-based
microspheres attenuated the adverse indirect paracrine effects of pASC on conduction proper-
ties of cultured cardiomyocytes.
Supporting information
S1 Fig. Layout of the 60 electrodes in the MEA. Each electrode has a diameter of 100 μm and
an interelectrode distance of 700 μm. Numbers 1 to 4 represent stimulation positions. Abbrevi-
ation: MEA: multi-electrode array.
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